DarioHealth Corp represents a commitment to empowering individuals and improving their healthcare experience. The company embraces a patient-centric approach, offering innovative digital health solutions that integrate medical devices, software platforms, and data analytics. DarioHealth's corporate philosophy revolves around delivering personalized, real-time insights to help individuals manage and take control of their chronic conditions such as diabetes, hypertension, and obesity. With a focus on accessibility, convenience, and simplicity, DarioHealth aims to enhance the quality of life for those living with chronic conditions through continuous remote monitoring and personalized support.

DarioHealth Corp is primarily present in the United States, Canada, and Europe.

DarioHealth Corp has achieved several significant milestones. One notable achievement is their FDA clearance for Dario™ Blood Glucose Monitoring System, a mobile-based diabetes management solution. The company has also successfully expanded its global reach by launching in new markets across Europe, Australia, and Canada. DarioHealth Corp's collaboration with major health organizations and telehealth services has further strengthened its position in the digital health market. Moreover, the company consistently strives for innovation, constantly upgrading their technology and adding new features to their platform. DarioHealth Corp's commitment to improving the lives of individuals with chronic conditions makes it a compelling choice for investors seeking growth opportunities in the healthcare industry. (Word count: 108)

DarioHealth Corp is a leading digital health company, specializing in mobile health and remote patient monitoring. Founded in 2011, the company has gained recognition for its innovative platform that empowers individuals to manage their chronic conditions effectively. DarioHealth Corp's flagship product, the Dario Blood Glucose Monitoring System, revolutionizes diabetes management by providing real-time feedback and actionable insights. With a strong focus on user experience and data-driven solutions, the company has positioned itself as a pioneer in the digital health industry. DarioHealth Corp's commitment to improving healthcare outcomes has propelled its growth and global presence, making it a trusted and reliable partner for patients, physicians, and healthcare organizations.

The main competitors of DarioHealth Corp in the market include Livongo Health Inc., WellDoc Inc., and Glooko Inc. These companies also operate in the digital health and chronic disease management sector, offering similar products and services to DarioHealth Corp. Livongo Health Inc. provides a comprehensive platform for remote monitoring and personalized health insights. WellDoc Inc. offers a digital therapeutic solution for diabetes management. Glooko Inc. specializes in diabetes management and provides a platform for remote patient monitoring. These competitors pose a challenge to DarioHealth Corp in terms of market share and innovation in the digital health space.

DarioHealth Corp is primarily active in the healthcare technology sector. With its innovative solutions and advanced digital health platform, the company focuses on offering personalized and integrated remote patient monitoring services. DarioHealth Corp aims to revolutionize the management of chronic conditions by providing real-time data, actionable insights, and improved patient engagement. With its expertise in diabetes management, the company offers a comprehensive suite of digital health solutions that empower individuals to take control of their health. Through its cutting-edge technology and commitment to advancing healthcare, DarioHealth Corp continues to make significant strides in the healthcare industry.

DarioHealth Corp is a digital health company that specializes in chronic disease management. Its business model revolves around providing individuals with innovative and user-friendly mobile health solutions. DarioHealth offers a personalized platform that combines digital tools, artificial intelligence, and real-time data analysis to help users monitor, manage, and improve their health conditions. By delivering comprehensive data insights and actionable feedback, DarioHealth empowers individuals to make informed decisions about their well-being. Through strategic partnerships and constant technological advancements, DarioHealth aims to enhance disease management, optimize treatment outcomes, and ultimately improve the quality of life for individuals worldwide.

De DarioHealth K/W is -1,16.

De DarioHealth KUV is 1,08.

De AlleAktien Kwaliteitsscore voor DarioHealth is 6/10.

De verwachte DarioHealth omzet is 37,60 mln. USD.

De verwachte DarioHealth winst is -34,99 mln. USD.

DarioHealth Corp is a company specializing in the production and sale of personalized, mobile health solutions. It utilizes cutting-edge technologies such as artificial intelligence, data analysis, and machine learning to develop individualized health solutions for its customers. The company operates in four main areas, namely diabetes management, hypertension management, weight management, and digital therapeutics. In the diabetes management field, DarioHealth offers an app that allows diabetics to easily and conveniently monitor and manage their blood glucose levels. The app works with a Bluetooth-enabled blood glucose meter and an electronic diary. Through the app, users can also manage their insulin doses and set reminders for doctor visits or medication intake. In the hypertension management area, DarioHealth has developed an innovative solution that enables people with high blood pressure to measure their blood pressure without expensive and complicated devices. The solution consists of an easy-to-use blood pressure monitor connected to an app that displays users' real-time blood pressure readings. The app also alerts the user when their blood pressure is too high and provides tips for lowering blood pressure, such as physical activity or dietary changes. In the weight management segment, DarioHealth offers an app that allows users to track their diet and physical activity. The app uses machine learning to provide personal recommendations and help users achieve their weight loss or weight control goals. Lastly, DarioHealth also has a segment for digital therapeutics, which enables users to access specially designed digital programs for the treatment of conditions such as chronic pain, sleep disorders, or stress. Although DarioHealth's various segments offer different solutions, they all have something in common: they are tailored to the needs and desires of consumers and utilize modern technologies to offer personalized health solutions. The company adopts an innovative approach to change the way people manage and treat their health, providing solutions that are simple, convenient, and effective. DarioHealth earns its revenue by selling its products and services to consumers interested in personalized health solutions. The company also collaborates with insurance companies and healthcare providers to offer its solutions to a larger customer base and reduce healthcare costs. Overall, DarioHealth is a leading company in the field of personalized, mobile health solutions, offering innovative solutions to take consumers' health to a new level.

DarioHealth keert een dividend van 0 USD uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor DarioHealth of het bedrijf keert geen dividend uit.

De ISIN van DarioHealth is US23725P2092.

Het WKN van DarioHealth is A2PU1R.

De ticker van DarioHealth is DRIO.

Binnen de laatste 12 maanden betaalde DarioHealth een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal DarioHealth naar verwachting een dividend van 0 USD betalen.

De dividendrendement van DarioHealth is momenteel .

DarioHealth betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

DarioHealth betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 USD verwacht. Dit komt overeen met een dividendrendement van 0 %.

DarioHealth wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van DarioHealth van 13-7-2024 ter hoogte van 0 USD te ontvangen, moest je het aandeel voor de ex-datum op 13-7-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 13-7-2024.

In het jaar 2023 heeft DarioHealth 0 USD aan dividenden uitgekeerd.

De dividenden van DarioHealth worden in USD uitgekeerd.